| Literature DB >> 24059355 |
Paolo Durando1, Giovanni Sotgiu, Fabio Spigno, Mauro Piccinini, Giovanni Mazzarello, Claudio Viscoli, Francesco Copello, Alessandro Poli, Filippo Ansaldi, Giancarlo Icardi.
Abstract
BACKGROUND: The screening of both healthcare workers and students attending teaching hospitals for latent tuberculosis infection (LTBI) is recommended in hospitals of many countries with a low-incidence of TB, including Italy, as a fundamental tool of tuberculosis (TB) control programs. The aim of the study was to estimate the prevalence of LTBI and evaluate the main risk-factors associated with this condition in a cohort of healthcare Italian students.Entities:
Mesh:
Year: 2013 PMID: 24059355 PMCID: PMC3848912 DOI: 10.1186/1471-2334-13-443
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Demographic, epidemiological and clinical characteristics of a cohort of healthcare students trained at a regional tertiary adult acute care reference hospital in Italy
| Mean (SD) age, year | 23.6 (3.1) | |
| Males, n (%) | 279/733 (38.1) | |
| Country of birth, n (%) | Italy | 692/733 (94.4) |
| Israel | 12/733 (1.6) | |
| Albania | 9/733 (1.2) | |
| Others | 20/733 (2.7) | |
| Born in a high TB incidence country*, n (%) | 12/733 (1.6) | |
| Potential professional exposure, n (%) | Clinical students | 595/733 (81.2) |
| Preclinical students | 138/733 (18.8) | |
| Year of attendance, n (%) | Fourth | 270/733 (36.8) |
| Fifth | 169/733 (23.1) | |
| Others | 294/733 (40.1) | |
| BCG immunization, n (%) | 13/733 (1.8) | |
| Positive TST, n (%) | 10/733 (1.4) | |
| Positive IGRA, n (%) | 4/10 (40) | |
SD Standard Deviation.
BCG Bacille Calmette-Guérin.
TST Tuberculin Skin Testing.
IGRA Interferon-γ Release Assay.
*High Incidence: ≥20 cases per 100,000 population (according to reference 23).
Proportion of positive tuberculin skin testing response stratified by the main collected variables
| Gender | Male | 3/279 (1.1), -0.001 – 0.023 | 0.75 |
| Female | 7/454 (1.5), 0.004 – 0.026 | ||
| Nationality | Italian | 6/692 (0.9), 0.002 – 0.016 | 0.001 |
| Migrant | 4/41 (9.8), 0.007 – 0.189 | ||
| TB incidence of the country of birth* | ≥20 cases per 100,000 population | 4/12 (33.3), 0.066 – 0.600 | <0.0001 |
| <20 cases per 100,000 population | 6/721 (0.8), 0.002 – 0.015 | ||
| Potential professional exposure calculated without the interference of subjects coming from countries at high-incidence of TB | Pre-clinical students | 3/136 (2.2), -0.003 – 0.046 | 0.09 |
| Clinical students | 3/585 (0.5), -0.001 – 0.011 | ||
| BCG immunization | Not vaccinated | 9/720 (1.3), 0.005 – 0.021 | 0.17 |
| Vaccinated | 1/13 (7.7), -0.068 – 0.222 | ||
CI Confidence Intervals.
BCG Bacille Calmette-Guérin.
TST Tuberculin Skin Testing.
*High Incidence: ≥20 cases per 100,000 population (according to reference 23).
Association between a positive tuberculin skin testing response and potential independent variables
| Increasing age, year | 1.09 | 0.10 (0.98–1.21) | 1.10 | 0.09 (0.99–1.22) |
| Male | 0.69 | 0.60 (0.18–2.71) | 0.66 | 0.56 (0.17–2.61) |
| Migrant | 12.36 | <0.001 (3.34–45.7) | 16.05 | <0.001 (3.63–70.91) |
| Born in a high TB incidence country* | 59.58 | <0.001 (14.06–252.58) | 102.80 | <0.001 (18.09–584.04) |
| BCG immunization | 6.58 | 0.09 (0.77–56.14) | 6.72 | 0.08 (0.78–57.69) |
OR Odds Ratio.
CI Confidence Intervals.
BCG Bacille Calmette-Guérin.
*High Incidence: ≥20 cases per 100,000 population (according to reference 23).